Immuno-inflammatory athero-arteriosclerosis induced by elastin peptides. Effect of age

Handbook on Immunosenescence: Basic Understanding and Clinical Applications

Volumn 9781402090639, Issue , 2009, Pages 1089-1116

  Robert, L ^a   Robert, A M ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antielastin antibodies; Aorta; Elastases; Elastin; Immune atherosclerosis; Vascular wall

Indexed keywords

EID: 84910011030     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-9063-9_54     Document Type: Chapter

References (100)

1. Antonicelli F, Bellon G, Debelle L, Hornebeck W. (2007) Elastin-elastases and inflamm-aging. Cur Topics Dev Biol 79:99-155
2. Archilla-Marcos M, Robert L (1993) Control of the biosynthesis and excretion of the elastase-type protease of human skin fibroblasts by the elastin receptor. Clin Physiol Biochem 10:86-91
3. Beaumont J-L, Jacotot B, Vilain C, Beaumont V (1965) Presence of an anti-beta-lipoprotein autoantibody in a myeloma seum. C R Acad Sci 260:5960-5962
4. Beaumont J-L (1965) Hyperlipidemia caused by anti-beta-lipoprotein antibodies. A new pathological entity C R Acad Sci 261:4563-4566
5. Beaumont V, Beaumont J-L (1968) Experimental hyperlipemia induced by immunization in the rabbit. Path Biol 16:870-876
6. Beaumont J-L (1969) Gamma globulins and hyperlipemia. Hyperlipemia caused by autoantibodies. Ann Biol Clin 27:611-635
7. Beaumont J-L (1970) Auto-immune hyperlipidemia. An atherogenic metabolic disease of immune origin. Rev Eur Etud Clin Biol 15:1037-1041
8. Beaumont J-L, Lemort N (1974) Anti-heparin immunoglobulins, a factor of thrombosis, hyperlipidemia and atherosclerosis. Path Biol 22:67-76
9. Bieth J (1978) Elastases: structure, function and pathological role. In: Robert L (ed) Frontiers in matrix biology, vol 6. Karger, Basel, pp 1-82
10. Bihari-Varga M, Gero S (1966) Role of intimal mucoid substances in the pathogenesis of atherosclerosis. Investigations on the components of the mucopolysaccharide-beta-lipoprotein complex formation in vitro. Acta Physiol Acad Sci Hung 29:273-281
11. Bihari-Varga M, Keller L, Landi A, Robert L (1884) Elastase-type activity, elastase inhibitory capacity, lipids and lipoproteins in the sera of patients with ischemic vascular disease. Atherosclerosis 50:273-281
12. Bihari-Varga M, Kadar A, Jacob M-P, Robert L (1986) Physicochemical and ultrastructural properties of cholesterol esters bound to elastin. Connect Tissue Res 15:43-55
13. Bing DK, Weygand J G M, Stavitsky AB (1967) Hemagglutination with aldehyde-fixed erythrocytes for assay of antigens and antibodies. Proc Soc Exptl Biol Med 124:1168
14. Bizbiz L, Bonithon-Kopp C, Ducimetière P, Berr C, Alperovitch A, Robert L (1996) Relation of serum elastase activity to ultrasonographically assessed carotid artery wall lesions and cardiovascular risk factors. The E VA study. Atherosclerosis 120:47-55
15. Bizbiz L, Alperovitch A, Robert L, and the E VA group (1997) Aging of the vascular wall: serum concentration of elastin peptides and elastase inhibitors in relation with cardiovascular risk factor. The E VA study. Atherosclerosis 131:73-78
16. Bourdillon M-C, Soleilhac J-M, Crouzet B, Robert L, Hornebeck W (1984) Influence of lipoproteins on elastase-type activity of arterial smooth muscle cells in culture. Cell Biol Internat Rep 8:415-421
17. Bürger M (1947) Altern und Krankheit. Georg Thieme, Leipzig
18. Burstein M, Samaille J (1959) Nouvelle méthode de séparation et de dosage des lipoprotéines de faible densité. Ann Biol Clin 17:23
19. Buxtorf J-C, Lorenzelli-Edouard L, Beaumont J-L (1981) Immunoglobulins and hyperlipoproteinemias. Biomedicine 35:90-93
20. Claire M, Jacotot B, Robert L (1976) Characterisation of lipids associated with macromolecules of the intercellular matrix of human aorta. Connect Tissue Res 4:61-71
21. Comper WD (ed) (1996) Extracellular Matrix, vol. I-II. Harwood Academic Publishers, Australia
22. Faury G, Ristori MT, Verdetti J, Jacob M-P, Robert L (1995) Effect of elastin peptides on vascular tone. J Vasc Res 32:112-119
23. Faury G, Chabaud A, Ristori MT, Robert L, Verdetti J (1997) Effect of age on the vasodilatatory action of elastin peptides. Mech Aging Dev 95:31-42
24. Faury G, Usson Y, Robert-Nicoud M, Robert L, Verdetti J (1998a) Nuclear and cytoplasmic free calcium level changes induced by elastin peptides in human endothelial cells. Proc Natl Acad Sci 95:2967-2972
25. Faury G, Garnier S, Weiss AS, Wallach J, Fülöp T Jr, Jacob M-P, Mecham RP, Robert L, Verdetti J (1998b) Action of tropoelastin and synthetic elastin sequences on vascular tone and on free calcium level in human vascular endothelial cells. Circ Res 82:328-336
26. Fülöp T Jr, Jacob M-P, Robert L (1989a) Determination of anti-elastin antibodies in normal and atherosclerotic human sera by ELISA. J Clin Lab Immunol 30:69-74
27. Fülöp T Jr, Jacob M-P, Robert L (1989b) Biological effects of elastin peptides. In: Robert L, Hornebck W (eds) Elastin and elastases, vol I. CRC Press, Boca Raton, pp 201-210
28. Fülöp T Jr, Varga Zs, Csongor J, Jacob M-P, Robert L, Leovey A, Foris G (1990a) Altered phosphatidylinositol breakdown in polymorphonuclear leukocytes with aging. In: Goldstein AL (ed) Biomedical advances in aging. Plenum Publishing, New York
29. Fülöp T Jr, Wei SM, Robert L, Jacob M-P (1990b) Determination of elastin peptides in normal and atherosclerotic human sera by ELISA. Clin Physiol Biochem 8:273-282
30. Fülöp T Jr, Barabas G, Varga Zs, Csongor J, Hauck M, Szücs S, Seres I, Mohacsi A, Kekessy D, Despont J-P Robert L, Penyige A (1992) Transmembrane signaling changes with age. Ann New York Acad Sci 673:165-171
31. Fülöp T Jr, Douziech N, Jacob M-P, Hauck M, Wallach J, Robert L (2001) Age-related alterations in the signal transduction pathways of the elastin-laminin receptor. Path Biol 49:339-348
32. Fülöp T Jr, Larbi A, Fortun A, Robert L, Khalil A (2005) Elastin peptides induced oxidation of LDL by phagocytic cells. Path Biol 53:416-423
33. Gardner DL (1965) Pathology of the connective tissue diseases Edward Arnold Publishers, London
34. Gero S, Gergely J, Jakab L, Székely J, Virag S, Farkas K, Czuppon A (1959) Inhibition of cholesterol atherosclerosis by immunisation with beta-lipoprotein. Lancet 7088:6-7
35. Gero S, Gergely J, Dévényi T, Jakab L, Székely J, Virag S (1960) Role of mucoid substances of the aorta in the deposition of lipids. Nature 187:152-153
36. Gero S (1967) Some data on the influence of cholesterol atherosclerosis by immunological means. Rev Atheroscler (Paris) 9(Suppl 1):194-198
37. Groult V, Hornebeck W, Robert L, Pouchelet M, Jacob M-P (1998) Interactions of elastic fibers with fibroblasts - A time-lapse cinematographic study. Path Biol 46:507-516
38. Hornebeck W, Partridge M (1975a) Conformational changes in fibrous elastin due to calcium ions. Eur J Biochem 51:73-78
39. Hornebeck W, Derouette J-C, Robert L (1974b) Isolation, purification and properties of aortic elastase. FEBS Lett 58:66-70
40. Hornebeck W, Potazman JP, De Cremoux H, Bellon G, Robert L (1983) Elastase-type activity of human serum., Clin Physiol Biochem 1:285-292
41. Hornebeck W, Tixier J-M, Robert L (1986) Inducible adhesion of mesenchymal cells to elastic fibers: elastonectin. Proc Natl Acad Sci 83:5517-5520
42. Jacob M-P, Brechemier D, Robert L, Hornebeck W (1982) Variation of elastase-type protease activity and elastin biosynthesis in rabbit aorta induced by cholesterol diet. Artery 10:310-316
43. Jacob M-P, Hornebeck W, Robert L (1983) Studies on the interaction of cholesterol with soluble and insoluble elastins. Int J Biol Macromol 5:275-278
44. Jacob M-P, Hornebeck W, Lafuma C, Bernaudin JF, Robert L, Godeau G (1984) Ultrastructural and biochemical modifications of rabbit arteries induced by immunisation with soluble elastin peptides. Exp Mol Pathol 41:171-190
45. Jacob M-P, Fülöp T Jr, Foris G, Robert L (1987a) Effect of elastin peptides on ion fluxes in mononuclear cells, fibroblasts and smooth muscle cells. Proc Natl Acad Sci 84:995-999
46. Jacob M-P, Moura AM, Tixier J-M, Lafuma C, Robert AM, Robert L, Worcel M (1987b) Prevention by calcitonin of the pathological modifications of the rabbit arterial wall induced by immunisation with elastin peptides: effect on vascular smooth muscle permeability. Exper Mol Pathol 46:345-356
47. Jacotot B, Beaumont J-L, Monnier G, Szigeti M, Robert B, Robert L (1973) Role of elastic tissue in cholesterol deposition in the arterial wall. Nutr Metabol 15:46-58
48. Joseph JA, Roth GS (1990) Loss of agonist-receptor efficacy in senescence: possible decrements in second messenger function and calcium mobilisation. In: Bergener M, Ermini M, Stähelin HB (eds) Challenges in aging. Acadamic Press, New York, pp 167-184
49. Labat-Robert J, Robert L (2007) The effect of cell-matrix interactions and aging on the malignant process. In: Advances in cancer research, vol. 98. Elsevier, Amsterdam, pp 221-259
50. Lansing AI (ed) (1959) The arterial wall. The Williams & Wilkins Co, Baltimore
51. Lorenzelli-Edouard L, Marie F, Beaumont J-L (1980) Antilipoprotein autoimmune hyperlipidemia. The Ig-Lp test. Biomedicine 33:160-163
52. Minick CR, Murphy GE, Campbell WG Jr (1966) Experimental induction of athero-arteriosclerosis by the synergy of allergic injury to arteries and lipid rich diet. J Exp Med 124:635
53. Olsson AG (ed) (1987) Atherosclerosis. Biology and clinical science. Churchill Livingstone, Edinburgh
54. Perdomo JJ, Gounon P, Schaeverbeke M, Schaeverbeke J, Groult V, Jacob MP, Robert L (1994) Interaction between cells and elastin fibers: an ultrastructural and immunocytochemical study. J Cell Physiol 158:451-458
55. Péterszegi G, Mandet C, Texier S, Robert L, Bruneval P (1997a) Lymphocytes in human atherosclerotic plaques exhibit the elastin-laminin receptor: potential role in atherogenesis. Atherosclerosis 135:103-107
56. Péterszegi G, Texier S, Robert AM, Moulias R, Robert L (1997b) Increased elastase and cathepsin G activity in activated lymphocytes from aged patients. Role of denutrition and dementia. Arch Gerontol Geriatr 25:285-298
57. Péterszegi G, Texier S, Robert L (1997c) Human helper and memory lymphocytes exhibit an inducible elastin-laminin receptor. Int Arch Allergy Immunol 114:218-223
58. Péterszegi G, Texier S, Robert L (1999) Cell death by overload of the elastin-laminin receptor on human activated lymphocytes: protection by lactose and melibiose. Eur J Clin Invest 29:166-172
59. Renais J, Groult N, Scebat L, Lenegre J (1968) Pouvoir antigénique et pathogène du tissu artériel. In: Le rôle de la paroi artérielle dans l'atherogénèse. Colloque International CNRS, Paris
60. Robert AM, Grosgogeat Y, Reverdy V, Robert B, Robert L (1971) Lésions artérielles produites chez le lapin par immunisation avec l'élastine et les glycoprotéines de structure de l'aorte. Études biochimiques et morphologiques. Atherosclerosis 13:427-449
61. Robert B, Szigeti M, Derouette J-C, Robert L, Bouissou H, Fabre M-T (1971) Studies on the nature of the microfibrillar component of elastic fibers. Eur J Biochem 21:507-516
62. Robert B, Hornebeck W, Robert L (1974a) Cinétique hétérogène de l'interaction élastine-élastase. Biochimie 56:239-244
63. Robert B, Derouette J-C, Robert L (1974b) Mise en évidence de protéases à activité élastolytique dans les extraits d'aortes humaines et animales. C R Acad Sci Paris 278:3251-3254
64. Robert B, Robert L, Robert AM (1974c), Elastrine, élastase et artériosclérose. Path Biol 22:661-669
65. Robert B, Robert L (1975) Aortic elastase, its role in the degradation of arterial elastin. In: Peeters H (ed) Protids of biological fluids. Pergamon Press, pp 413-418
66. Robert L, Poullain N (1963) Étude sur la structure de l'élastine et le mode d'action des élastases. I. Nouvelle méthode de préparation des dérivés solubles de l'élastine. Bull Soc Chim Biol 45:1317-1326
67. Robert L, Parlebas I (1965) Biosynthèes in vitro des glycoprotéines de la cornée. Bull Soc Chim Biol 47:1853-1866
68. Robert L, Stein F, Pezess MP, Poullain N (1967), Propriétés immunochimiques de l'élastine. Leur importance dans l'atherosclerose. Arch Maladies du Cœur 60(Suppl. 1):233-241
69. Robert L, Robert AM, Moczar M, Moczar E (1968) Constituants macromoléculaires de la paroi artérielle. Antigénicité et rôle dans l'atherosclérose. In: Le rôle de la paroi artérielle dans l'atherosclérose. Colloque CNRS, pp 395-424, Paris
70. Robert L, Robert B, Medema J, Houtman J P W (1970a) Surface areas of elastin samples determined by krypton-85 adsorption. Biochim Biophys Acta 214:235-237
71. Robert L, Robert B, Robert AM (1970b) Molecular biology of elastin as related to aging and atherosclerosis. Exptl Gerontol 5:339-356
72. Robert L, Robert B, Houtman J P W, Stack MV (1971) Flow calorimetry of the sorption of butanol to elastin preparations and comparison with surface areas determined by Krypton-85 adsorption., Biochim Biophys Acta 251:370-375
73. Robert L, Robert B (1973) Immunology and aging. Gerontologia 19:330-335
74. Robert L, Jacob M-P, Szemenyei K, Robert AM (1984a) Pharmacological properties of elastin peptides, their action on serum and aorta lipids and on the atherosclerotic process. In: Carlson LA, Olsson AG (eds) Treatment of hyperlipoproteinemia, Raven Press, New York, pp 185-188
75. Robert L, Chaudière J, Jacotot B (1984b) Interaction between lipids and the intercellular matrix of the arterial wall: its role in the evolution of atherosclerotic lesions. In: Malinow R, Blaton VH (eds) Regression of atherosclerotic lesions. Plenum Publishing Corporation, pp 145-173
76. Robert L, Jacob M-P, Frances C, Godeau G, Hornebeck W (1984c) Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review. Mech Aging Dev 28:155-166
77. Robert L, Moczar M, Moczar E (eds) (1985) Methods of connective tissue research. Frontiers in matrix biology, vol 10. Karger, Basel
78. Robert L, Labat-Robert J, Hornebeck W (1986) Aging and atherosclerosis. Atherosclerosis Rev 14:143-170, Raven Press, New York
79. Robert L, Jacob M-P, Fülöp T Jr, Timar J, Hornebeck W (1989) Elastonectin and the elastin receptor. Path Biol 37:736-741
80. Robert L (1996) Aging of the vascular wall and atherogenesis: role of the elastin-laminin receptor. Atherosclerosis 123:169-179
81. Robert L (1998) Mechanisms of aging of the extracellular matrix. Role of the elastin-laminin receptor. Novartis Price Lecture. Gerontology 44:307-317
82. Robert L (1999a) Aging of the vascular wall and atherosclerosis. Exper Gerontol 34:491-501
83. Robert L (1999b) Interaction between cells and elastin, the elastin receptor. Connect Tissue Res 40:75-82
84. Robert L, Labat-Robert J (2000) Aging of connective tissues, from genetic to epigenetic mechanisms. Biogerontology 1:123-131
85. Roth GS (1979) Hormone receptor changes during adulthood and senescence: significance for aging research. Federation Proc 38:1910-1914
86. Rouis M, Nigon F, Lafuma C, Hornebeck W, Chapman J (1990) Expression of elastase activity by human monocyte-macrophages is modulated by cellular cholesterol content, inflammatory mediators and phorbol myristate acetate. Arteriosclerosis 10:246-255
87. Scebat L, Renais J, Iris L, Groult N, Lenegre J (1966) Lésions artérielles produites chez le lapin par des injections de broyat d'aorte homologue et hétérologue. Arch Mal Cœur 59 (suppl.no1) Rev Athér Arter Périph, pp. 56-72
88. Scebat L, Renais J, Groult N, Iris L, Lenegre J (1967), Arterial lesions produced in rabbits by injections of pulverized rat aorta. Preliminary study. Rev Atheroscler (Paris) 9:249-262
89. Stein F, Pezess M-P, Robert L, Poullain N (1965) Anti-elastin antibodies in normal and pathological human sera. Nature 207:312-313
90. Szigeti I, Ormos J, Jako J, Toszegi A (1960) The atherogenic effect of immunisation with homologous complex great vessel wall in rabbit. Acta Allergologica (suppl. VII): 374-387
91. Szigeti I, Jako I, Doman J (1968) Study of the antigenic and immunopathological effects of structural proteins of the mammalian arterial wall and their role in the pathogenesis of atherosclerosis. In: colloque CNRS No 169: Le rôle de la paroi artérielle dans l'athérogénèse, pp 387-394, Paris
92. Szigeti M, Monnier G, Jacotot B, L. Robert (1972) Distribution of ingested 14C-cholesterol in the macromolecular fractions of rat connective tissue. Connect Tissue Res 1:145-152
93. Timar J, Diczhazi Cs, Ladanyi A, Raso E, Hornebeck W, Robert L, Lapis K (1995) Interaction of tumor cells with elastin and the metastatic phenotype. In: The molecular biology and pathology of elastic tissues. John Wiley & Sons, Chichester pp 321-333
94. Trentham DE (1984) Immunity to type II collagen in rheumatoid arthritis: a current appraisal. Proc Soc Exp Biol Med 176:85-104
95. Urry DW (1980) Sequential polypeptides of elastin. Structural properties and molecular pathologies. Front Matrix Biology. In: Robert AM, Robert L (eds) Biology and pathology of elastic tissues, vol 8. Karger, Basel, pp 78-103
96. Varga Z, Kovacs EM, Paragh G, Jacob M-P, Robert L, Fülöp T Jr (1988) Effect of elastin peptides and N-Formyl-methionyl-Leucyl-Phenylalanine on cytosolic free calcium in polymorphonuclear leucocytes of healthy middle-aged and elderly subjects. Clin Biochem 21:127-130
97. Varga Z, Jacob M-P, Robert L, Fülöp T Jr (1989) Identification and signal transduction mechanism of elastine peptide receptor in human leucocytes. FEBS Lett 258:5-8
98. Varga Z, Jacob M-P, Robert L, Csongor J, Fülöp T Jr (1997) Age-dependent changes of k-elastin stimulated effector functions of human phagocytic cells: relevance for atherogenesis. Exp Gerontol 32:653-662
99. Wei S. M, Erdei J, Fülöp T Jr, Robert L, Jacob M-P (1993) Elastine peptide concentration in human serum: variation with antibodies and elastin peptides used for the enzyme-linked immunosorbent assay. J Immunol Methods 164:175-187
100. White FN, Grollman A (1964) Experimental periarteritis nodosa in the rat Arch Pathol 78:31